The Effects of Metformin on Morbidity and Mortality in Elderly Patients (NCT04530058)
The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)
🩺 Plain-English Summary (8th-Grade Level)
Elderly patients have an increased susceptibility to burns and a substantial mortality that has not significantly changed over the last three decades. Elderly burn patients not only have an augmented response to burn but also express a prolonged hypermetabolic response.Glucose metabolism with insulin resistance is a hypermetabolic response pathway that profoundly affects post-burn outcomes. The aim if this study is to determine whether metformin can improve morbidity and mortality in elderly burn patients. The investigators hypothesize that metformin will improve clinical outcomes and mortality of elderly burn patients by alleviating the complex inflammatory and hypermetabolic responses after burn.
Who can join: Review the eligibility criteria below.
Location: Hamilton Health Sciences Centre — Hamilton, Ontario
Age range: 60 Years to 99 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hamilton Health Sciences Centre — Hamilton, Ontario
📞 Contact the Study Coordinator
Phone: (905) 521-2100
Email: marc.jeschke@hhsc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Burns
- Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns — Phoenix, Arizona
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection — Oklahoma City, Oklahoma
- A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells — Hamilton, Ontario
- A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes — Winnipeg, Manitoba
- 4-Aminopyridine to Treat Skin Burns — Tucson, Arizona
Explore by condition: All Burns clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.